TXG 10x Genomics, Inc. Class A Common Stock Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
16:18
Aug 20
Aug 20
AI Moderna vaccine news lifts TEM/TXG.
Speaker attributes TEM/TXG rally to AI-assisted Moderna vaccine Phase 3 news, implying AI-driven biotech sentiment; no personal position stated.
MED
15:41
Aug 19
Aug 19
Notes ten consecutive green weeks for TXG
Notes an extended streak of ten consecutive green weeks for the stock.
LOW
15:36
Aug 11
Aug 11
Short-term trade, co-entry with ABCL
Author lists TXG as a current short-term trade alongside ABCL; no specific catalyst provided.
LOW
19:02
Aug 10
Aug 10
Recommends biotech exposure amid improving technicals.
Author recommends exposure to biotech and genome stocks, supported by earlier context noting increasing revenue and a technical breakout.
MED
16:26
Jul 09
Jul 09
TXG had a strong double-digit day after the author noted volume ramping up and a major diagonal.
TXG had a strong double-digit day after the author noted volume ramping up and a major diagonal breakout, but no position is stated.
LOW
19:32
Jul 06
Jul 06
Buy TXG as a technical breakout (diagonal breakout.
Buy TXG as a technical breakout (diagonal breakout, rising volume) combines with a fundamental dislocation — stock is down 80% from ATH while revenue and financials are improving, suggesting significant mispricing.
MED
09:04
Jun 10
Jun 10
The author presents a large diversified basket of favorite names across sectors as where they.
The author presents a large diversified basket of favorite names across sectors as where they are positioned for the next few years, but the 30+ tickers default to watch due to the basket size rule.
17:37
Jun 09
Jun 09
Author discloses current positioning in TXG as a Health name.
Author discloses current positioning in TXG as a Health name, framing the dip as a buying opportunity with a multi-year hold thesis.
MED
13:19
Feb 06
Feb 06
Buy TXG on the open per internal team recommendation.
Buy TXG on the open per internal team recommendation; active buy signal triggered pre-market with explicit instruction to add to position.
MED
About TXG Analyst Coverage
Buzzberg tracks TXG (10x Genomics, Inc. Class A Common Stock) across 3 sources. 4 bullish vs 0 bearish calls from 3 analysts. Sentiment: predominantly bullish (44%). 9 total trade ideas tracked. Past 7 days: 1 watch. Latest voices: incomesharks, __con_, Keith McCullough.